Oral mucosal drug delivery systems offer a viable alternative by enabling transmucosal absorption, bypassing hepatic metabolism, and facilitating both rapid and sustained drug release.
Cannabinoid Pain Relief: Evidence-Based Clinical Guide
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, with preclinical evidence showing reduced pain-related neuronal activity. Current research demonstrates that cannabinoid interactions with these ion...
Cannabidiol Supplement Use and WADA Drug Testing Results
Clinical Takeaway Broad-spectrum CBD supplements, even at moderate daily doses, can produce urine levels of prohibited cannabinoids like CBG that may trigger positive anti-doping tests, particularly when combined with exercise. Athletes using...
The “entourage effect” isn’t bro science, minor cannabinoids and terpenes physically bind to …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Entourage EffectCannabinoid PharmacologyTerpenesProduct SelectionClinical Research Why This Matters Understanding molecular mechanisms behind cannabinoid interactions...
Cannabinoids and Pain: Pharmacology and Evidence | Omnicuris
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pain ManagementMedical EducationCannabinoid PharmacologyChronic PainClinical Evidence Why This MattersPain remains the most common indication...
Cannabinoid Pain Relief: Sodium Channel Modulation Research
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve transmission, based on laboratory evidence from multiple studies. This mechanism may explain part of cannabinoids' pain-relieving effects, though human...
Cannabis use patterns and perception of acute pain during brief abstinence: sex-dependent associations with circulating cannabinoid levels.
CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch | CED Clinic PainWithdrawalSex DifferencesClinical StudyAbstinence JournalPsychopharmacologyStudy TypeClinical StudyPopulationHuman participants Why This MattersThis study addresses a critical clinical gap...
Can CBD gummies make you depressed? – Pathologica
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthCbdDepressionDrug SafetyDosing Why This MattersThe question of CBD's potential depressive effects reflects a...
Cannabis Meets Drug Metabolism: What We Know—and Don’t Know—About Cannabinoids and CYP450 Enzymes
Recognising potential interactions between cannabinoids and other drugs could enhance understanding of their pharmacological effects, improve the efficacy and safety profiles of cannabinoid-based therapies, and encourage further exploration into this under-researched area of psychopharmacology.
Assessments of Evoked and Spontaneous Pain Following Administration of Gabapentin and the Cannabinoid CB
Cannabinoid CB We compared the impact of LY2828360 on evoked and spontaneous pain in a spared nerve injury (SNI) model using a within-subjects design in rats…